COVID19: EMA reviews new Valneva vaccine

The European Medicines Agency (EMA) announced its human medicines committee (CHMP) started a rolling review of VLA2001, a COVID-19 vaccine developed by French company Valneva. The CHMP’s decision to start the rolling